News & Event

2020년 May 25일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “COVID-19 return as a boomerang if we can’t control the disease in developing countries…Cooperation needed to supply low-cost vaccine”

Published in the Joongang Ilbo This article is only available in Korean. Original Article
2020년 April 28일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “Neglecting COVID-19 in developing countries, may result in a boomerang return effect”

Published in the Joongang Ilbo This article is only available in Korean. Original Article
2020년 April 27일

Interview: Younbeen Kim, CEO of RIGHT Fund “Korean research could play a pivotal role in the fight against infectious diseases”

Published in the HelloDD This article is only available in Korean. Original Article
2020년 April 21일

Interview: Younbeen Kim, CEO of RIGHT Fund “The public-private partnership is critical regarding the infectious disease research”

Published in the Dong-A Daily News This article is only available in Korean. Original Article
2020년 April 20일

Column: Younbeen Kim, CEO of RIGHT Fund “COVID-19 vaccine development is not only the responsibility of life science companies”

Published in the Korea Economic Daily, Hankyunghealth. This article is only available in Korean. Original Article
2020년 April 11일

Featured News: What is the RIGHT Fund which President Moon and Bill Gates mention, regarding the development the COVID19 vaccine?

Published in the Medicalnews This article is only available in Korean. Original Article  
2020년 April 2일

Interview: Paul Herrling, Chairman of the Selection Committee, RIGHT Fund “More public-private partnership needed to spur research of less-profitable areas”

Published in the Korea Biomedical Review & the Korean Doctors’ Weekly The new coronavirus pandemic has affected more than 800,000 people around the world as of […]
2020년 March 20일

Interview: Younbeen Kim, CEO of RIGHT Fund “The development of vaccines and therapeutics for COVID-19 shouldn’t be given up”

Published in the Maeil Business Newspaper This article is only available in Korean. Original Article
2020년 March 16일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “RIGHT Fund will provide active support for research on endemic and emerging infectious diseases such as COVID-19”

Published in the Hankook Ilbo This article is only available in Korean. Original Article
2020년 March 9일

Featured News: “The Government, Pharmaceutical companies and the Gates Foundation together support ODA, leveraging Korea’s innovation and strength”

Published in Online the Maeil Business Newspaper This article is only available in Korean.   Original Article
2020년 February 27일

Featured News: Blocking extensively drug-resistant tuberculosis prevent crisis of public health

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 26일

Featured News: New Diagnostic For Safe Administration of Malaria Drugs…Screening For G6PD Deficiency

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 23일

Featured News: The key of new single-dose antimalarial drug is a Continuous Process Development

PPublished in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 21일

Featured News: Supply of hexavalent vaccines to developing countries could completely eradicate polio

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 19일

Featured News: Leveraging Korean’s technology in development of MGH-Harvard’s ‘Novel Cholera Conjugate Vaccine’

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 12일

Interview: Younbeen Kim, CEO of RIGHT Fund “RIGHT Fund Makes the Life Change”

RIGHT Fund Makes the Life Change Published in the The DOCTOR’S NEWS   This article is only available in Korean. Original Article
2020년 January 15일

Featured News: Global cooperation is critical in the war of humans and viruses

Published in the The Kyunghynag Daily This article is only available in Korean. Original Article
2019년 December 9일

Interview: Dr. Andrin Oswald, Director of The BMGF “Korea, Leading Country of Life Science is anticipated to contribute global health”

Korea, Leading Country of Life Science is anticipated to contribute global health Published in the Yakup.   This article is only available in Korean. Original Article
2019년 November 25일

Interview: Leadership of five Korean life science companies investing in RIGHT Fund “RIGHT Fund invests 50 billion… seeking of new vaccines and therapeutics”

RIGHT Fund invests 50 billion… seeking of new vaccines and therapeutics Published in the Yakup.   This article is only available in Korean.   Original Article
2019년 July 24일

Interview: Younbeen Kim, CEO of RIGHT Fund “Contribute to global public health leveraging Korean technology”

Published in the The Dailypharm   This article is only available in Korean.   Original Article
2019년 July 18일

Interview: Younbeen Kim, CEO of RIGHT Fund “RIGHT Fund aims to use Korean innovation for global health equity”

Korea Biomedical Review_RIGHT Fund aims to use Korean innovation for global health equity Infectious diseases remain a leading cause of deaths worldwide and have been disproportionately […]
2019년 July 17일

Featured News: “RIGHT Fund reveals 1st investment into public health projects in developing countries”

Korea Biomedical Review_RIGHT Fund reveals 1st investment into public health projects in developing countries Bryan Yeung, senior director of strategy at RIGHT Fund, announces plans for […]
2019년 July 17일

2019 RIGHT FUND INVESTMENT FORUM

2019년 February 6일

Column: Younbeen Kim, CEO of RIGHT Fund “there is no safe zone for infectious diseases in the era of globalization”

Published in the The Hankyoreh.   This article is only available in Korean.   Original Article
2018년 November 22일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “Develop ODA models to help low income countries by developing incrementally modified drugs”

Published in the Korea Economic Daily, Hankyunghealth.   This article is only available in Korean.   Original Article